US Patent Issued to The Fifth Medical Center of Chinese PLA General Hospital on March 31 for "DNA vaccine capable of effectively treating and/or preventing type 1 diabetes and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,141, issued on March 31, was assigned to The Fifth Medical Center of Chinese PLA General Hospital (Beijing).

"DNA vaccine capable of effectively treating and/or preventing type 1 diabetes and use thereof" was invented by Yongzhi Xi (Beijing) and Song Yun (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is use of a recombinant nucleic acid construct containing a B7-2-PE40 exotoxin fusion gene in the preparation of a DNA vaccine or medicament for treatment and/or prevention of type 1 diabetes. The DNA vaccine can reduce blood glucose in patient with type 1 diabetes, restore the secretion of insulin of the patients per se, and reduce t...